BGB-A317-3111-10188-101

Recruiting

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

Beigene Study ID info

BGB-A317-3111-10188-101

ClinicalTrials.gov ID info

China Drug Trials ID info

CTR20220463

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents